Security key
35104E100
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)
CUSIP: 35104E100
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 42,433,937
- Total 13F value
- $859,819,319
- Share change
- +520,093
- Put/Call ratio
- 272%
- SEC-reported price per share
- $20.26
- Number of holders
- 111
- Value change
- +$24,792,782
- Number of buys
- 61
- Number of sells
- 47
- Shares outstanding
- 51,571,939
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2023
Institutions
111
Top holders
10
FDMT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
4D Molecular Therapeutics, Inc. SEC filings
4D Molecular Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 35104E100
Recent filing periods:
Ownership snapshot
Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 9.3%
Showing 1-6 of 15 holder rows.
Quick read
VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 9.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
VIKING GLOBAL INVESTORS LP
9.3%
RA CAPITAL MANAGEMENT, L.P.
8.1%
BVF INC/IL
7.8%
BlackRock Finance, Inc.
6.1%
Venrock Adviser, LLC
5.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
9.3%
|
$60,950,145
4,787,914 shares
|
— | 30 Sep 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
8.1%
|
$52,997,676
4,163,211 shares
|
— | 30 Sep 2023 |
| BVF INC/IL |
13F
Company
|
7.8%
|
$51,014,367
4,007,413 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
6.1%
|
$39,764,397
3,123,676 shares
|
— | 30 Sep 2023 |
| Venrock Adviser, LLC |
13F
Company
|
5.8%
|
$38,190,000
3,000,000 shares
|
— | 30 Sep 2023 |
| Deep Track Capital, LP |
13F
Company
|
5.4%
|
$35,365,302
2,778,107 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
111
Shares
42,433,937
Rows available
111
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
110
Q4 2023 holders
111
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend